Osteopore Limited

OSX.AX

Medical - Instruments & Supplies · Healthcare

Exchange

Australian Securities Exchange

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Winston Score History

The full picture

Osteopore Limited is a Singapore-based medical device company that makes biodegradable bone scaffolds used in surgery. These scaffolds are tiny implants placed inside the body to help bones heal and regrow after injury or surgery. The company sells its products to hospitals and surgeons, mainly in the orthopedic and craniofacial surgery markets.

Osteopore earns revenue by selling its implants directly to healthcare providers and through distribution partners across Asia, Europe, and other regions. The company's key advantage is its proprietary 3D-printed scaffold technology, which is designed to dissolve naturally in the body over time, removing the need for a second surgery to take out the implant. However, with an operating margin of nearly negative 100%, Osteopore is spending far more than it earns, meaning the main risk is whether it can grow sales fast enough to reach profitability before needing to raise more capital.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+12.2% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+30.6% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

8.6%ownership

Insiders own a meaningful stake in the company

Cash Runway

~1 months

A$626,972 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Osteopore Limited has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

46.8%

Healthy — 46.8% gross margin

Profit after running costs

Operating Margin

-106.6%

Losing money on operations — -106.6%

Return on the money invested

ROCE

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+8.7%

Steady sales growth (+8.7% YoY)

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

-83.8%

Burning cash (-83.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial